<DOC>
	<DOCNO>NCT02814448</DOCNO>
	<brief_summary>The purpose study test two innovative device , CryoPen® thermocoagulator , gas-based cryotherapy determine whether novel device produce equivalent improve destruction cervical tissue compare gas-based cryotherapy . Tissue destruction single freeze versus double freeze treatment CryoPen gas-based cryotherapy also compare .</brief_summary>
	<brief_title>An Innovative Treatment Cervical Pre Cancer</brief_title>
	<detailed_description>The primary objective study test hypothesis CryoPen® thermocoagulator provide non-inferior depth cervical tissue necrosis compare traditional CO2-based cryotherapy test single versus double freeze application . The secondary objective study determine CryoPen® thermocoagulator achieve depth necrosis 3.5 mm , accept depth require eradicate 95 % cervical precancer , observe relationship depth necrosis variation cervical anatomy .</detailed_description>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Between 25 65 year old . Scheduled hysterectomy reason cervical precancer cancer Diagnosis uterine , endometrial , ovarian cancer jeopardize tissue cervix permit Histological evaluation cervix interfere woman 's current diagnosis Woman consent participate inform study Normal Pap Smear HPV test past 3 year Pregnancy History cervical surgery past 5 year Presence cervical lesion preinvasive invasive cervix * Current Pelvic Inflammatory Disorder severe acute cervicitis Cervix shape disfigure hard reach</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>